Infinium Pharmachem Share Price | Infinium Pharmachem Stock Screener
INFINIUM
Pharmaceuticals
Track Infinium Pharmachem share price live with TickJournal's free stock screener.
Check INFINIUM 52-week high low for the annual price range and momentum.
Use the Infinium Pharmachem stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Infinium Pharmachem Market Cap
₹337.37 Cr.
INFINIUM P/E Ratio (TTM)
-
Infinium Pharmachem P/B Ratio
3.06
EPS (TTM)
₹5.60
Dividend Yield
-
Debt to Equity
0.38
INFINIUM 52 Week High
-
Infinium Pharmachem 52 Week Low
-
Operating Margin
-
Profit Margin
-
INFINIUM Revenue (TTM)
-
EBITDA
-
Net Income
-
Total Assets
₹198.00
Total Equity
₹125.00
Infinium Pharmachem Share Price Chart
Screen Infinium Pharmachem share price with an interactive chart. Analyse INFINIUM price trends and volatility across different timeframes.
Infinium Pharmachem Company Profile - Fundamental Screener
Screen Infinium Pharmachem company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for INFINIUM shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE0MRE01011
Infinium Pharmachem Balance Sheet Screener
Screen INFINIUM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total Assets | 198 | 86 | 71 | 59 | 34 | 22 |
| Current Assets | 140 | 65 | 51 | 44 | 26 | 18 |
| Fixed Assets | 24 | 20 | 19 | 4 | 5 | 4 |
| Liabilities | ||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 10 | 8 | 10 | 14 | 6 | 6 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||
| Total Equity | 125 | 60 | 24 | 14 | 7 | 4 |
| Share Capital | 16 | 14 | 5 | 1 | 1 | 1 |
| Reserves & Surplus | 94 | 45 | 18 | 12 | 6 | 3 |
Infinium Pharmachem Income Statement Screener - Profit & Revenue Analysis
Screen Infinium Pharmachem income statement and profit fundamentals.
Analyze INFINIUM quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Infinium Pharmachem share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 158 | 137 | 116 | 100 | 71 | 39 |
| Expenses | 0 | 139 | 117 | 98 | 89 | 66 | 36 |
| EBITDA | 0 | 19 | 20 | 17 | 11 | 6 | 3 |
| Operating Profit % | 0.00% | 11.00% | 14.00% | 14.00% | 10.00% | 7.00% | 6.00% |
| Depreciation | 0 | 3 | 3 | 1 | 1 | 1 | 1 |
| Interest | 0 | 4 | 2 | 3 | 2 | 1 | 1 |
| Profit Before Tax | 0 | 12 | 15 | 13 | 9 | 4 | 1 |
| Tax | 0 | 4 | 4 | 3 | 2 | 1 | 0 |
| Net Profit | 0 | 8 | 12 | 10 | 7 | 3 | 1 |
| EPS | 0.00 | 5.60 | 8.12 | 6.82 | 60.07 | 26.80 | 9.19 |
Infinium Pharmachem Cash Flow Screener - Liquidity Fundamentals
Screen INFINIUM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|
| Operating Activities | -29 | -13 | 9 | 12 | 7 | 3 |
| Investing Activities | -27 | -4 | -5 | -7 | -5 | -1 |
| Financing Activities | 79 | 23 | -3 | -2 | -1 | -1 |
| Net Cash Flow | 23 | 6 | 1 | 4 | 1 | 1 |
Infinium Pharmachem Shareholding Pattern Screener
See Infinium Pharmachem shareholding pattern with promoter, FII, and DII holdings.
Check Infinium Pharmachem promoter holding and ownership changes for INFINIUM on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Sept | 2024-Mar | 2024-Sept | 2024-Nov | 2023-Feb | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 64.91% | 65.24% | 59.91% | 73.05% | 73.05% | 65.24% | 100.00% | 100.00% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.22% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 31.96% | 32.00% | 37.21% | 23.85% | 23.97% | 32.05% | 0.00% | 0.00% |
| Other Holding | 2.91% | 2.76% | 2.88% | 3.10% | 2.98% | 2.71% | 0.00% | 0.00% |
| Shareholder Count | 1,061 | 958 | 1,052 | 771 | 947 | 998 | 17 | 17 |
Infinium Pharmachem Share Dividend Screener - Share Yield Analysis
Check Infinium Pharmachem dividend history with payout and yield data.
View Infinium Pharmachem dividend details including ex-dates and amounts for INFINIUM stock.
Infinium Pharmachem Stock Index Membership
See which indices include Infinium Pharmachem stock.
Check INFINIUM index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Infinium Pharmachem Market Events Screener - Corporate Actions
Get Infinium Pharmachem corporate actions including splits, bonuses, and buybacks.
Check Infinium Pharmachem stock events that may affect INFINIUM share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 71.56% | ||
| Bonus | 1:1 | -1.11% | ||
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -1.29% |
| 2025-08-21 | 2025-08-21 | Quarterly Result Announcement | NA | 6.05% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | 12.70% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | 2.10% |
| 2024-10-23 | 2024-10-23 | Extraordinary General Meeting | NA | -8.11% |
| 2024-07-06 | 2024-07-06 | Extraordinary General Meeting | NA | 2.78% |
Infinium Pharmachem Competitors Screener - Peer Comparison
Screen INFINIUM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 452,395 | 41.18 | 54,729 | 9.71% | 10,980 | 64.89 |
| Divis Laboratories | 177,744 | 72.40 | 9,712 | 18.67% | 2,191 | 64.06 |
| Torrent Pharmaceuticals | 147,112 | 65.64 | 11,539 | 6.99% | 1,911 | 58.52 |
| Cipla | 115,246 | 29.94 | 27,712 | -2.46% | 3,783 | 69.78 |
| Dr Reddys Laboratories | 111,183 | 26.84 | 33,593 | -0.44% | 3,998 | 59.87 |
| Mankind Pharma | 102,743 | 57.32 | 12,744 | 20.90% | 2,007 | 73.37 |
| Lupin | 101,761 | 19.41 | 27,488 | 19.98% | 5,345 | 46.11 |
| Zydus Life Science | 99,844 | 20.25 | 23,511 | 18.55% | 4,615 | 69.47 |
| Aurobindo Pharma | 87,004 | 25.19 | 32,346 | 9.43% | 3,484 | 73.83 |
| Laurus Labs | 71,202 | 80.32 | 6,813 | 21.03% | 884 | 80.26 |
Infinium Pharmachem Company Announcements - News Screener
Screen INFINIUM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.